The bidding period for the Anthem Biosciences IPO ended yesterday, July 16, 2025. The allocation procedure is anticipated to be completed on Thursday, July 17, 2025. Anthem Biosciences plans to list its IPO on BSE and NSE, with a provisional listing date set for Monday, July 21, 2025.
Steps to Verify Anthem Biosciences IPO Allotment Status on NSE
The procedure to verify the Anthem Biosciences IPO Allotment Status on NSE is as follows:
- Open the Application Status page of NSE here.
- Choose ”Equity & SME IPO Bid Details”
- Select ‘Anthem Biosciences’ from the list of companies.
- Enter your IPO application number and PAN details.
- Press the submit button to verify the information regarding the share allotment.
Steps to Verify Anthem Biosciences IPO Allotment Status on BSE
The procedure to verify the Anthem Biosciences IPO Allotment Status on BSE is as follows:
- Open the Application Status page of BSE here.
- Choose ” as the issue type.
- Select Anthem Biosciences from the list of companies.
- Enter your IPO application number and PAN details.
- Verify the captcha by clicking on the ‘I am not a Robot’ box.
- Press the submit button to verify the information regarding the share allotment.
Anthem Biosciences IPO Allotment Status Verification Kfin Technologies
- Go to the IPO registrar’s website using this link – https://kosmic.kfintech.com/ipostatus/
- Select Anthem Biosciences Limited from the dropdown menu for Select IPO.
- Select either Application No, Demat Account, or PAN.
- Fill in the information according to the chosen option.
- Input the Captcha code and press Submit.
Your Anthem Biosciences IPO allotment status will be displayed on the screen.
Anthem Biosciences IPO Details
The overall size of the Anthem Biosciences IPO amounted to ₹3,395.00 crores. The matter was solely an Offer for Sale (OFS) of 5.96 crore shares. The price range for the issue is established at ₹540 – ₹570 per share. The issue’s minimum lot size is 26, and one can invest a minimum of ₹14,040 to apply.
The book-running lead managers for the Anthem Biosciences IPO are JM Financial Limited, Citigroup Global Markets India, J P Morgan India, and Nomura Financial Advisory and Securities (India) Pvt Ltd., with Kfin Technologies Limited serving as the registrar for the issue.
Also Read – Anthem Biosciences IPO Review
Anthem Biosciences IPO GMP Details
As per Livemint, the Grey Market Premium (GMP) for Anthem Biosciences Limited was ₹144 on July 17, 2025, at 8:30 a.m. This suggests that the anticipated listing price for the shares might be approximately ₹714, referencing the upper limit of the price band at ₹570. The anticipated profit per share is 25.26%.
Source: Livemint Media Report dated July 17, 2025
Disclaimer: The GMP (Grey Market Premium) price is an unverified market-related figure and lacks a clear foundation. The aforementioned is according to news presented in the media report and is intended solely for informational purposes. The investor must conduct their own analysis/research prior to using it for making any investment decisions. We do not participate in, trade, or conduct business in the grey market, nor do we support or promote trading in the grey market.
Anthem Biosciences Business Overview
Anthem Biosciences, established in 2006 and based in Bengaluru, is a prominent Indian Contract Research, Development & Manufacturing Organization (CRDMO). It provides comprehensive services throughout drug discovery, development, and manufacturing for small molecules as well as biologics. The organization caters to more than 550 clients in 44 nations, with significant inputs from regulated markets such as the US, Europe, and Japan.
In FY25, Anthem declared a revenue of ₹1,844.6 crore along with a net profit of ₹451.3 crore.
